EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients

Metalia Puspitasari, Auliana Ratri Prabandari Hidayat, Wynne Wijaya, Yulia Wardhani, Prenali Dwisthi Sattwika, J Jonny, Ira Puspitawati

Blood Purification · 2024

DOI: 10.1159/000539396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Metalia Puspitasari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. Hauptthemen laut MEDLINE: Renal Dialysis, Kidney Failure, Chronic, Biomarkers, C-Reactive Protein. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Combined hemodialysis (HD) and hemadsorption (HA) therapy has shown the highest clearance rates for middle and large-sized uremic toxin molecules and reduced mortality rates among maintenance HD (MHD) patients. This study aimed to investigate the effectiveness of combined HD and HA therapy in patients undergoing MHD.

Methods

Forty patients with end-stage renal disease (ESRD) were divided into three groups: HD only (14), HD + biweekly HA (14), and HD + weekly HA (12). The duration of the study was 8 weeks. Uremic toxins (β2-microglobulin, leptin, parathyroid hormone), inflammatory markers (interleukin-6, C-reactive protein), and symptoms (appetite, pruritus, sleep quality) were assessed before the start and at the completion of therapy. Changes in the parameters were compared between the three groups. Mean differences of parameters in each group were also compared between before and after therapy.

Results

Decrease in BUN level (−61.34 mg/dL [95% CI: −71.33 to −51.34], p < 0.0001) and pruritus score (−3.93 [95% CI: −6.89 to −0.97], p = 0.013) was significantly larger in HD + biweekly HA group compared to the others. Only HD + biweekly HA group showed significant reductions in CRP level (−0.10 mg/L [95%: −0.18 to −0.01], p = 0.034), VAS appetite score (10.43 [95% CI: 4.99–15.87], p = 0.001), and pruritus score (−3.93 [95% CI: −6.89 to −0.97], p = 0.013) after therapy. Both HD + biweekly HA (−2.79 [95% CI: −4.97 to −0.60], p = 0.016) and HD + weekly HA group (−2.33 [95% CI: −4.59 to −0.08], p = 0.044) exhibited a significant improvement in sleep quality score after therapy.

Conclusions

HD combined with a biweekly HA is associated with a greater reduction in BUN level and better improvement of pruritus in ESRD patients compared to HD alone. HD + biweekly HA can significantly reduce CRP levels, alleviate pruritus, improve appetite, and enhance sleep quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisKidney Failure, ChronicBiomarkersC-Reactive ProteinHumansMaleFemaleMiddle AgedUremic ToxinsAgedAdultPruritusInterleukin-6UremiaInflammationHemoperfusionbeta 2-Microglobulin

Stichwörter der Autor:innen

End-stage renal diseaseHemadsorptionHemodialysis

Substanzen

BiomarkersC-Reactive ProteinUremic ToxinsInterleukin-6beta 2-Microglobulin

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Department of Oncology, University of Oxford, Oxford, UK.
  • Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Department of Internal Medicine, Gatot Soebroto Army Hospital, Jakarta, Indonesia.
  • Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Zitieren

APA

Puspitasari, M., Hidayat, A. R. P., Wijaya, W., Wardhani, Y., Sattwika, P. D., Jonny, J., & Puspitawati, I. (2024). Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients. Blood Purification. https://doi.org/10.1159/000539396

Vancouver

Puspitasari M, Hidayat ARP, Wijaya W, Wardhani Y, Sattwika PD, Jonny J, et al. Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients. Blood Purification. 2024. doi:10.1159/000539396

BibTeX
@article{Puspitasari2024,
  author = {Puspitasari, Metalia and Hidayat, Auliana Ratri Prabandari and Wijaya, Wynne and Wardhani, Yulia and Sattwika, Prenali Dwisthi and Jonny, J and Puspitawati, Ira},
  title = {Effectiveness of Combined Hemodialysis-Hemadsorption Therapy in Improving Uremic Toxin Clearance, Inflammatory Markers, and Symptoms in Maintenance Hemodialysis Patients},
  journal = {Blood Purification},
  year = {2024},
  doi = {10.1159/000539396}
}
Kostenlos starten →